That could be the case. What draws me to this business is the quality of management + them being major investors and the staggering, almost infinite number of therapies the Stem Cell platform (protected by Patents on IP) can generate.
This can create decades of rapid growth and is unique.
I’m watching many biotech companies but NON come close to this management team’s care and skill in finding funding without killing shareholders.
They get so much done in so little.
And soon they will be able to be profitable.
An amazing find for those with sufficient time horizons.
News 
Market Data 
Discover 
